| Click here to review our online proxy materials. | |
| Sepracor Announces Full Support of PhRMA's Revised Code on Interactions with Healthcare Professionals | |
| Sepracor Inc. Presented Leadership Award for Contributions to Growth of Community | |
| Sepracor Announces Phase III Data for Eslicarbazepine Acetate Presented at Ninth Eilat Conference on New Anti-Epileptic Drugs | |
| Sepracor Completes Acquisition of Oryx Pharmaceuticals and Expands Operations in Canada | |